Antineutrophil cytoplasmic antibodies in chronic liver diseases: Prevalence, titre, specificity and IgG subclass

Journal of Hepatology

Volumn 24, Issue 5, 1996, Pages 581-586

  Bansi, Devinder ^a   Chapman, Roger W ^a   Fleming, Kenneth ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antineutrophil cytoplasmic antibodies; IgG subclass; Primary sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0030014042     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80144-9     Document Type: Article

References (26)

1. Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmic antibodies and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-2
2. Falk RJ, Terrell RS, Charles LA, Jeanette JC. Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci 1990; 87: 4115-9.
3. Niles JL, McCluskey RT, Ahmed MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74: 1888-93
4. Falk RJ, Jeanette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 3: 1651-7.
5. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202-10.
6. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic autoantibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385-9.
7. Klein R, Eisenberg J, Weber P, Seibold F, Berg P. Significance and specificity of antibodies to neutrophils detected by western blotting for the serologic diagnosis of primary sclerosing cholangitis. Hepatology 1991; 14: 1147-52.
8. Lo SK, Fleming KA, Chapman RW. Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33: 1370-5.
9. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33: 657-62.
10. Mulder AL, Horst G, Haagsma E, Limburg P, Kleinbenker J, Kallenberg C. Prevalence and characterisation of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17:411-7.
11. Oudkerk Pool MO, Ellerbroek PM, Meuwissen SGM. Serum antineutrophil autoantibodies in inflammatory bowel disease: localisation studies of the related antigen(s). Gastroenterology 1991; 10: A236.
12. Ellerbroek PM, Oudkerk Pool M, Ridwan, BU, Dolman KM, Von Blomberg BME, von dem Borne AEG, Meuwissen SGM, Goldschmeding R. Neutrophil cytoplasmic antibodies (pANCA) in ulcerative colitis. J Clin Pathol 1994; 47: 257-62.
13. Mecarelli LH, Nusbaum P, Noel LH. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992; 90: 79-84.
14. Peen E, Almer S, Bodemar B, Ryden BO, Sjolin T, Tejle K, Skogh T. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease. Gut 1993; 34: 56-62.
15. Lo SK, Chapman RW, Cheeseman P, Charlton CP, Walker-Smith JA, Mieli-Vergani G. Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood? Gut 1993; 34: 199-202.
16. Bansi DS, Fleming KA, Chapman RW. IgG subclass distribution of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis. J Pathol 1995; 175 Suppl: 146A.
17. Vidrich A, Landers C, Sandborn B, Wiesner RH, Lindor KD, Targan SR. IgG subclass distinguishes between PSC and UC ANCA. Gastroenterology 1993; 104: A1015.
18. Pokorny CS, Norton I, McCaughan GW, Selby WS. Antineutrophil cytoplasmic antibody: aprognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol 1994; 9:40-4.
19. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Neutrophil cytoplasmic autoantibodies in ulcerative colitis. Comparison with other colitides/diarrhoeal diseases. Gastroenterology 1991; 100: 1590-6.
20. Targan S, Landers C, Vidrich A, Czaja A. High level perinuclear antineutrophil cytoplasmic antibodies are present in almost all autoimmune hepatitis type 1 patients. Gastroenterology 1994; 106: A997.
21. Lawrence SP, Sherman KE, Lawson JM, Goodman ZD. A 39-year-old man with chronic hepatitis. Semin Liver Dis 1994; 14: 97-105.
22. Schur PH. IgG subclasses- a review. Ann Allergy 1987; 58: 89-95.
23. Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992; 37: 1606-11.
24. Minuk GY, Sutherland LR, Pappas SC. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988; 2: 22-7.
25. Chapman RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 1-4.
26. Pokorny CS, McCaughan GW, Gallagher ND, Selby WS. Sclerosing cholangitis and biliary tract calculi - primary or secondary? Gut 1992: 33: 1376-80.